Anti-inflammatory Effect of Curcuma longa and Allium hookeri Co-treatment via NF-κB and COX-2 Pathways.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
31 03 2020
Historique:
received: 17 12 2019
accepted: 19 03 2020
entrez: 3 4 2020
pubmed: 3 4 2020
medline: 2 12 2020
Statut: epublish

Résumé

Although inflammation is a host defense mechanism, chronic inflammation mediates several diseases, including cancer, allergy, asthma, and autoimmune diseases, and reportedly, it is associated with a 60% mortality rate. There are several reports on the anti-inflammatory effects of Curcuma longa and Allium hookeri. However, although they can be used as culinary materials and have biological effects, they are not effective anti-inflammatory agents. In this study, we evaluated the synergic effect of C. longa and A. hookeri in order to confirm the possibility of a new anti-inflammatory agent. Based on cell viability and cytokine analyses, the appropriate ratio of C. longa and A. hookeri was confirmed using an air pouch animal model. Then, the anti-inflammatory effect of C. longa and A. hookeri co-treatment was evaluated by measuring the immune cell count and cytokines in the exudate and by comparing the morphological changes and cytokines in inflamed skin samples. Additionally, we evaluated the NF-κB/COX-2 pathway and iNOS levels. The active constituents detected in C. longa were demethoxycurcumin and bisdemethoxycurcumin, and that detected in A. hookeri was methylsulfonylmethane. An in vitro assessment determined the appropriate drug ratio as 3:7. In a carrageenan-induced inflammatory model, co-treatment effectively suppressed inflammatory cytokines, including IFN-γ, IL-1β, IL-6, IL-13, and IL-17, and recovered inflammation-related morphological changes in the skin. The anti-inflammatory effect of the co-treatment was mediated through the NF-κB/COX-2 pathway and iNOS inhibition. We concluded that co-treatment with C. longa and A. hookeri synergistically inhibited inflammation via the NF-κB/COX-2/iNOS pathway.

Identifiants

pubmed: 32235914
doi: 10.1038/s41598-020-62749-7
pii: 10.1038/s41598-020-62749-7
pmc: PMC7109078
doi:

Substances chimiques

Anti-Inflammatory Agents 0
Inflammation Mediators 0
NF-kappa B 0
Plant Extracts 0
Cyclooxygenase 2 EC 1.14.99.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5718

Références

Philip, H. The inflammation theory of disease. EMBO Reports 13(11), 968–970, https://doi.org/10.1038/embor.2012.142 (2012).
doi: 10.1038/embor.2012.142
Pahwa, R., Jialal, I., Chronic inflammation. StatPearls [Internet], https://www.ncbi.nlm.nih.gov/books/NBK493173 (June 4, 2019).
Sostres, C., Gargallo, C. J., Arroyo, M. T. & Lanas, A. Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDS, aspirin and coxibs) on upper agstointestinal tract. Best Pract. Res. Clin. Gastroenterol. 24(2), 121–132, https://doi.org/10.1016/j.bpg.2009.11.005 (2010).
doi: 10.1016/j.bpg.2009.11.005
Zhang, J.-M. & An, J. Cytokines, Inflammtion and pain. Int. Anestesiol. Clin. 45(2), 27–37, https://doi.org/10.1097/AIA.0b013e318034194e (2007).
doi: 10.1097/AIA.0b013e318034194e
Musolino, C. et al. Inflammatory and anti-inflammatory equilibrium, proliferative and antiproliferative balance: the role of cytokines in multiple myeloma. Mediators Inflamm. 2017, 1852517, https://doi.org/10.1155/2017/1852517 (2017).
doi: 10.1155/2017/1852517 pubmed: 5635476 pmcid: 5635476
Surh, Y.-J. et al. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation. Mut. Res. 480-481, 243–268, https://doi.org/10.1016/s0027-5107(01)00183-X (2001).
doi: 10.1016/s0027-5107(01)00183-X
Bulugonda, R. K. et al. Magniferin from Pueraria tuberosa reduces inflammation via inactivation of NLRP2 inflammasome. Sci Rep-UK 7, 42683, https://doi.org/10.1038/srep42683 (2017).
doi: 10.1038/srep42683
Devi, V. K., Jain, N. & Valli, K. S. Imprtance of novel drug delivery systems in herbal medicines. Pharmacogn. Rev. 4, 27–31, https://doi.org/10.4103/0973-7847.65322 (2010).
doi: 10.4103/0973-7847.65322 pubmed: 3249899 pmcid: 3249899
Shehaz, A., Rehman, G. & Lee, Y. S. Curcumin in inflammatory diseases. Biofactors 39, 69–77, https://doi.org/10.1002/biof.1066 (2013).
doi: 10.1002/biof.1066
Henrotin, Y. et al. Biological actions of curcumin on articular chondrocytes. Osteoarthritis Cartilage 18, 141–149, https://doi.org/10.1016/j.joca.2009.10.002 (2010).
doi: 10.1016/j.joca.2009.10.002
Maithilikarpagaselvi, N., Sridhar, M. G., Swaminathan, R. P. & Sripradha, R. Curcumin inhibits hyperlipidemia and hepatic fat accumulation in high-fructose-fed male wistar rat. Pharm. Biol. 54, 2857–2863, https://doi.org/10.1080/13880209.2016.1187179 (2016).
doi: 10.1080/13880209.2016.1187179
Yadav, S. K. et al. Tumeric (curcumin) remedies gastroprotective action. Pharmacogn. Rev. 7, 42–46, https://doi.org/10.4103/0973-7847.112843 (2013).
doi: 10.4103/0973-7847.112843 pubmed: 3731878 pmcid: 3731878
Oh, H. N. et al. Tyrosinase inhibition antioxidant effect and cytotoxicity studies of the extracts of Cudrania tricuspidata fruit standardized in chlorogenic acid. Molecules. 24(18), E3266, https://doi.org/10.3390/molecules24183266 (2019).
doi: 10.3390/molecules24183266
Kim, J. E. et al. Anti-inflammatory effect of Allium hookeri on carrageenan-induced air pouch mouse model. PloS One 12(12), e0190305, https://doi.org/10.1371/journal.pone.0190305 (2017).
doi: 10.1371/journal.pone.0190305 pubmed: 5744995 pmcid: 5744995
Park, D. E. et al. Antimicrobial and anti-inflammatory effects of ethanol extract of Corylopsis coreana Uyeki Flos. Pharmacogn. Mag. 13(50), 286–292, https://doi.org/10.4103/0973-1296.204554 (2017).
doi: 10.4103/0973-1296.204554 pubmed: 5421428 pmcid: 5421428
Kim, Y. H. et al. The anti-inflammatory effects of methylsulfonylmethane on lipopolysaccharide-induced inflammatory responses in murine macrophages. Biol. Pharm. Bull. 32, 651–656, https://doi.org/10.1248/bpb.32.651 (2009).
doi: 10.1248/bpb.32.651
Shoenfeld, Y., Sherer, Y. & Harats, D. Artherosclerosis as an infectious, inflammatory and autoimmmune disease. Trends Immunol. 22(6), 293–295, https://doi.org/10.1016/S1471-4906(01)01922-6 (2001).
doi: 10.1016/S1471-4906(01)01922-6
Kourilovitch, M., Galarza-Maldonado, C. & Ortiz-Prado, E. Diagnosis and classification of rheumatoid arthritis. J. Autoimmun. 48-49, 26–30, https://doi.org/10.1016/j.jaut.2014.01.027 (2014).
doi: 10.1016/j.jaut.2014.01.027
Durham, A. L., Caramori, G., Chung, K. F. & Adock, I. M. Targeted anti-inflammatory therapeutics in ashtma and chronic obstructive lung disease. Transl. Res. 167(1), 192–203, https://doi.org/10.1016/j.trsl.2015.08.004 (2016).
doi: 10.1016/j.trsl.2015.08.004 pubmed: 4728194 pmcid: 4728194
Hoffmann, G., Wirleitner, B. & Fuchs, D. Potential role of immune system activation-associated production of enopterin derivatives in human. Inflamm. Res. 52(8), 313–321, https://doi.org/10.1007/s00011-003-1181-9 (2003).
doi: 10.1007/s00011-003-1181-9
Zhang, J. Yin and yang interplay of IFN-γ in inflammation and autoimmune disease. J. Clin. Invest. 117(4), 871–873, https://doi.org/10.1172/JCI31860 (2007).
doi: 10.1172/JCI31860 pubmed: 1838954 pmcid: 1838954
Wan, B. et al. Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis. J. Immunol. 177(12), 8844–8850, https://doi.org/10.4049/jimmunol.177.12.8844 (2006).
doi: 10.4049/jimmunol.177.12.8844
Harrington, L. E. et al. Interleukin 17-producing CD4+ effector T cells develop via a lineasge distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6(11), 1123–1132, https://doi.org/10.1038/ni1254 (2005).
doi: 10.1038/ni1254
Sawitzki, B. et al. IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J. Exp. Med. 201, 1925–1935, https://doi.org/10.1084/jem.20050419 (2005).
doi: 10.1084/jem.20050419 pubmed: 2212028 pmcid: 2212028
Philip, R. & Epstein, L. B. Tumor necrosis factor as immunomodulator and mediator monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1. Nature 323, 86–89 (1986).
doi: 10.1038/323086a0
Monaco, C., Nanchahal, J., Taylor, P. & Feldmann, M. Anti-TNF therapy: past, present and future. Int. Immunol. 27, 55–62, https://doi.org/10.1093/intimm/dxu102 (2015).
doi: 10.1093/intimm/dxu102
Lee, R. A. & Eisen, D. B. Treatment of hidradenitis suppurativa with biologic medications. J. Am. Acad. Dermatol. 73, S82–S88, https://doi.org/10.1016/j.jaad.2015.07.053 (2015).
doi: 10.1016/j.jaad.2015.07.053
Probert, L. TNF and its receptors in the CNS: the essential, the desirable and the deleterious effects. Neurosicience 302, 2–22, https://doi.org/10.1016/j.neuroscience.2015.06.038 (2015).
doi: 10.1016/j.neuroscience.2015.06.038
Tanaka, T., Narazaki, M. & Kishimoto, T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb. Perspect. Biol. 6(10), a016295, https://doi.org/10.1101/cshperspect.a016295 (2014).
doi: 10.1101/cshperspect.a016295 pubmed: 4176007 pmcid: 4176007
Hoving, J. C. Targeting IL-13 as a host-directed therapy against ulcerative colitis. Front. Cell. Infect. Microbiol. 8, 395, https://doi.org/10.3389/fcimb.2018.00395 (2018).
doi: 10.3389/fcimb.2018.00395 pubmed: 6232290 pmcid: 6232290
May, R. D. & Fung, M. Strategies targeting the IL-4/IL-13 axes in disease. Cytokine 75(1), 89–116, https://doi.org/10.1016/j.cyto.2015.05.018 (2015).
doi: 10.1016/j.cyto.2015.05.018
Lee, G. S., Choi, K. C., Han, H. J. & Jeung, E. B. The classical and a non-classical pathways associated with NF-κB are involved in estrogen-mediated regulation of calbindin-D9k gene in rat pituitary cells. Mol. Cell. Endocrinol. 1–2, 42–50, https://doi.org/10.1016/j.mce.2007.07.009 (2007).
doi: 10.1016/j.mce.2007.07.009
Wei, X. et al. Hydrogen sulfide inhalation improves neurological outcome via NF-κB-mediated inflammatory pathway in a rat model of cardiac arrest and resuscitation. Cell. Physiol. Biochem. 36, 1527–1538, https://doi.org/10.1159/000430316 (2015).
doi: 10.1159/000430316
Chandrasekaran, C. V. et al. Immune-stimulatory and anti-inflammatory activities of Curcuma longa extract and its polysaccharide fraction. Pharmacognosy Res. 5(2), 71–79, https://doi.org/10.4103/0974-8490.110527 (2013).
doi: 10.4103/0974-8490.110527 pubmed: 3685767 pmcid: 3685767
Uchio, R., Murosaki, S. & Ichikawa, H. Hot water extract of turmeric (Curcuma longa) prevents non-alcoholic steatohepatitis in mice by inhibiting hepatic oxidative stress and inflammation. J. Nutr. Sci. 7, e36, https://doi.org/10.1017/jns.2018.27 (2018).
doi: 10.1017/jns.2018.27 pubmed: 30627433 pmcid: 30627433
Wilken, R., Veena, M. S., Wang, M. B. & Srivatsan, E. S. Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol. Cancer 10, 12, https://doi.org/10.1186/1476-4598-10-12 (2011).
doi: 10.1186/1476-4598-10-12 pubmed: 3055228 pmcid: 3055228
Kunnumakkara, A. B., Bordoloi, D., Harsha, C. & Banik, K. Curcumin mediates anticancer effect by modulating multiple cell signaling pathways. Clin Sci. (Lond) 131(15), 1781–1799, https://doi.org/10.1042/CS20160935 (2017).
doi: 10.1042/CS20160935
Sandur, S. K. et al. Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis 28(8), 1765–1773, https://doi.org/10.1093/carcin/bgm123 (2007).
doi: 10.1093/carcin/bgm123
Barrager, E. & Schauss, A. G. Methylsulfonylmethane as a treatment for seasonal allergic rhinitis: additional data on pollen counts and symptom questionnaire. J. Altern. Complement. Med. 9(1), 15–16, https://doi.org/10.1089/107555303321222874 (2003).
doi: 10.1089/107555303321222874
Kim, L. S. et al. Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial. Osteoarthr Cartilage 14(3), 286–294, https://doi.org/10.1016/j.joca.2005.10.003 (2006).
doi: 10.1016/j.joca.2005.10.003
Guimaraes-Stabili, M. R. et al. Systemic administration of curcumin or piperine enhances the periodontal repair: a preliminary study in rats. Clin Oral Investig 23, 3297–3306, https://doi.org/10.1007/s00784-018-2755-9. (2019).
doi: 10.1007/s00784-018-2755-9.
Srivastava, N. S. & Srivastava, R. A. K. Curcumin and quercetin synergistically inhibit cancer cell proliferation in multiple cancer cells and modulate Wnt/beta-catenin signaling and apoptotic pathways in A375 cells. Phytomedicine 52, 117–128, https://doi.org/10.1016/j.phymed.2018.09.224 (2019).
doi: 10.1016/j.phymed.2018.09.224
Chen, L., Liu, T., Wang, Q. & Liu, J. Anti-inflammatory effect of combined tetramethylpyrazine, resveratrol and curcumin in vivo. BMC Complement Altern Med 17, 017–1739, https://doi.org/10.1186/s12906-017-1739-7 (2017).
doi: 10.1186/s12906-017-1739-7
Choi, H.-J. et al. Development and validation of a HPLC-UV method for extraction optimization and biological evaluation of hot-water and ethanolic extracts of Dendropanax morbifera leaves. Molecules 23, 650, https://doi.org/10.3390/molecules23030650 (2018).
doi: 10.3390/molecules23030650 pubmed: 6017506 pmcid: 6017506

Auteurs

Soon-Young Lee (SY)

Department of Korean Medicine, Dongshin University, Naju, 58245, Korea.

Seung-Sik Cho (SS)

Department of Pharmacy, College of Pharmacy, Mokpo National University, Muan Jeonnam, 58579, Korea.

YongChun Li (Y)

School of Pharmaceutical Science, Zhengzhou University, Zhengzhou, Henan, 450001, P.R. China.

Chun-Sik Bae (CS)

College of Veterinary Medicine, Chonnam National University, Gwangju, 61186, Korea.

Kyung Mok Park (KM)

Department of Korean Medicine, Dongshin University, Naju, 58245, Korea. parkkim@dsu.ac.kr.

Dae-Hun Park (DH)

Department of Korean Medicine, Dongshin University, Naju, 58245, Korea. dhj1221@hanmail.net.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH